B. Anawalt

发表

B. Anawalt, 2016 .

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

A. Matsumoto, W. Bremner, B. Marck, 2013, Fertility and sterility.

A single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.

K. Herbst, W. Bremner, A. Coviello, 2004, The Journal of clinical endocrinology and metabolism.

Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction.

A. Mcneilly, A. Matsumoto, W. Bremner, 1996, The Journal of clinical endocrinology and metabolism.

Epidemiology of Male Hypogonadism.

B. Anawalt, A. Thirumalai, Arthi Thirumalai, 2022, Endocrinology and metabolism clinics of North America.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

Christina Wang, R. Swerdloff, A. Matsumoto, 2008, The Journal of urology.

Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1996, The Journal of clinical endocrinology and metabolism.

Testosterone administration suppresses adiponectin levels in men.

K. Herbst, A. Matsumoto, W. Bremner, 2005, Journal of andrology.

Male Hypogonadism

B. Anawalt, E. Darby, 2005, Treatments in endocrinology.

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

N. Watts, Kirk A Easley, A. Matsumoto, 2004, The Journal of clinical endocrinology and metabolism.

Male hypogonadism in the primary care clinic.

B. Anawalt, Nicole N Grant, 2003, Primary care.

Androgens in Primary Care

B. Anawalt, 2003 .

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

A. Matsumoto, J. Amory, B. Anawalt, 2002, Journal of andrology.

Testosterone treatment and mortality in men with low testosterone levels.

N. Smith, A. Matsumoto, M. Shores, 2012, The Journal of clinical endocrinology and metabolism.

Management of Incidental Thyroid Nodules

B. Anawalt, E. Lake, 2020 .

Male hormonal contraceptives: a potentially patentable and profitable product

Paul B. Cornia, B. Anawalt, 2005 .

Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery

K. Chansky, A. Matsumoto, W. Bremner, 2002, Journal of the American Geriatrics Society.

The association of obesity with sex hormone‐binding globulin is stronger than the association with ageing – implications for the interpretation of total testosterone measurements

A. Matsumoto, J. Amory, S. Page, 2015, Clinical endocrinology.

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism.

J. Hotaling, A. Matsumoto, T. Walsh, 2012, The Journal of urology.

T in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men

B. Anawalt, 2006 .

Treat Endocrinol 2005; 4 (5): 293-309

B. Anawalt, E. Darby, 2005 .

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

A. Matsumoto, W. Bremner, B. Marck, 2013, The Journal of clinical endocrinology and metabolism.

The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.

A. Matsumoto, W. Bremner, B. Marck, 2011, The Journal of clinical endocrinology and metabolism.

Serum LH correlates highly with intratesticular steroid levels in normal men.

A. Matsumoto, W. Bremner, J. Amory, 2010, Journal of andrology.

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

A. Matsumoto, W. Bremner, B. Marck, 2010, The Journal of clinical endocrinology and metabolism.

Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.

A. Matsumoto, W. Bremner, J. Amory, 2007, Journal of andrology.

Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception.

A. Matsumoto, W. Bremner, A. Coviello, 2007, Journal of andrology.

Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.

K. Herbst, B. Zirkin, T. Brown, 2005, The Journal of clinical endocrinology and metabolism.

Suppression Testosterone in Normal Men with Testosterone-Induced Gonadotropin Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular

K. Herbst, B. Zirkin, T. Brown, 2005 .

Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.

K. Herbst, B. Zirkin, T. Brown, 2004, Journal of andrology.

The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.

K. Herbst, A. Matsumoto, W. Bremner, 2003, The Journal of clinical endocrinology and metabolism.

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

A. Matsumoto, W. Bremner, M. Irwig, 2006, The Journal of clinical endocrinology and metabolism.

Detection of anabolic androgenic steroid use by elite athletes and by members of the general public

B. Anawalt, 2017, Molecular and Cellular Endocrinology.

Clinical decisions. Testosterone-replacement therapy.

R. Swerdloff, B. Anawalt, 2014, The New England journal of medicine.

The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men

Christina Wang, R. Swerdloff, A. Matsumoto, 2007 .

Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

K. Herbst, A. Matsumoto, W. Bremner, 2000, Fertility and sterility.

A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.

A. Matsumoto, W. Bremner, B. Anawalt, 1999, Journal of andrology.

Diagnosis and Management of Anabolic Androgenic Steroid Use.

B. Anawalt, 2019, The Journal of clinical endocrinology and metabolism.

Rational Use of Perioperative Corticosteroid Supplementation in Patients at Risk for Acute Adrenal Insufficiency

Paul B. Cornia, B. Anawalt, 2003 .

Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists

Frederick C W Wu, M. Grossmann, B. Anawalt, 2015, Clinical endocrinology.

Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1

J. Dominitz, B. Anawalt, J. Collins, 2011, Inflammatory bowel diseases.

Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins In Healthy Men.

Christina Wang, R. Swerdloff, W. Bremner, 2020, The Journal of clinical endocrinology and metabolism.

Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men

R. Swerdloff, W. Bremner, C. Wang, 2019, Andrology.

Relationships between endogenous and exogenous testosterone and cardiovascular disease in men

B. Anawalt, A. Thirumalai, Arthi Thirumalai, 2022, Reviews in endocrine & metabolic disorders.

Is Dihydrotestosterone a Classic Hormone?

B. Anawalt, 2017, Endocrine reviews.

A Multidisciplinary Care Pathway Significantly Increases the Number of Early Morning Discharges in a Large Academic Medical Center

Thomas O. Staiger, T. Staiger, R. Durvasula, 2015, Quality management in health care.

Is men's health just a single letter?

B. Anawalt, 2014, The Journal of clinical endocrinology and metabolism.

Daily salivary cortisol patterns in midlife women with hot flashes

C. Landis, N. Woods, S. Reed, 2016, Clinical endocrinology.

Androgenic Steroids Use and Abuse: Past, Present, and Future.

B. Anawalt, A. Thirumalai, Arthi Thirumalai, 2022, The Urologic clinics of North America.

Toxic masculinity in red blood cell units? Testosterone therapy in blood donors revisited

T. Kanias, L. Dumont, K. Hazegh, 2021, Transfusion.

Testosterone therapy and physical function.

S. Page, B. Anawalt, 2018, The lancet. Diabetes & endocrinology.

Approach to male infertility and induction of spermatogenesis.

B. Anawalt, 2013, The Journal of clinical endocrinology and metabolism.

Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.

B. Anawalt, 2010, The Journal of clinical endocrinology and metabolism.

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.

D. Siscovick, E. Boyko, E. Whitsel, 2001, The American journal of medicine.

Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures

E. Phelan, A. Matsumoto, B. Anawalt, 2019, Journal of Investigative Medicine.

Copper, Zinc, Manganese, and Magnesium Status and Complications of Diabetes Mellitus

C. Keen, J. W. Critchfield, C L Keen, 1991, Diabetes Care.

Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.

R. Swerdloff, W. Bremner, C. Wang, 1998, The Journal of clinical endocrinology and metabolism.

Acyline: the first study in humans of a potent, new gonadotropin-releasing hormone antagonist.

K. Herbst, W. Bremner, J. Amory, 2002, The Journal of clinical endocrinology and metabolism.

Klinefelter's syndrome

W. Bremner, J. Amory, C. A. Paulsen, 1984, The Lancet.

Testicular fine-needle aspiration for the assessment of intratesticular hormone concentrations

A. Matsumoto, W. Bremner, J. Amory, 2015, Asian journal of andrology.

Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

Frederick C W Wu, David Handelsman, Christina Wang, 2008, The Journal of clinical endocrinology and metabolism.

Hormonal Male Contraception: An Integrated Analysis Determinants of the Rate and Extent of Spermatogenic Suppression during

Frederick C W Wu, David Handelsman, Christina Wang, 2008 .

Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.

K. Herbst, A. Matsumoto, W. Bremner, 2005, Journal of andrology.

Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.

A. Matsumoto, W. Bremner, D. Robertson, 2004, The Journal of clinical endocrinology and metabolism.

Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.

A. Matsumoto, W. Bremner, A. Coviello, 2008, Fertility and sterility.

Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.

A. Matsumoto, W. Bremner, J. Amory, 2001, Journal of andrology.

Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.

S. Craft, M. Cherrier, K. Herbst, 2002, The Journal of clinical endocrinology and metabolism.

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11&bgr;-Methyl-19-Nortestosterone-17&bgr;-Dodecylcarbonate in Men

Christina Wang, R. Swerdloff, W. Bremner, 2018, The Journal of clinical endocrinology and metabolism.

Acceptability of the oral hormonal male contraceptive prototype, 11β-Methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial.

Christina Wang, R. Swerdloff, J. Amory, 2021, Contraception.

Medical risks for women who drink alcohol

K. Bush, K. Bradley, B. Anawalt, 1998, Journal of General Internal Medicine.

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

A. Matsumoto, W. Bremner, J. Amory, 2005, The Journal of clinical endocrinology and metabolism.

The Model T.

B. Anawalt, 2016, The Journal of clinical endocrinology and metabolism.

Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype.

Christina Wang, R. Swerdloff, W. Bremner, 2020, Contraception.

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.

A. Matsumoto, W. Bremner, J. Amory, 2007, Contraception.

Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.

D. Dewitt, B. Anawalt, Sarah E. Dick, 2002, The American journal of managed care.

Male Contraception: Hormonal Methods

S. Page, B. Anawalt, Carmen Abbe, 2021, Trends in Andrology and Sexual Medicine.

Serum testosterone is inversely, and sex hormone-binding globulin directly, associated with all-cause mortality in men.

C. Reid, G. Hankey, C. Ohlsson, 2020, The Journal of clinical endocrinology and metabolism.

Neuroendocrine aging in men. Andropause and somatopause.

G. Merriam, B. Anawalt, 2001, Endocrinology and metabolism clinics of North America.

Should survivors of childhood cancer or testicular cancer be screened for androgen deficiency?

A. Rogol, B. Anawalt, 2018, Clinical endocrinology.

Conclusions about testosterone therapy and cardiovascular risk

B. Yeap, B. Anawalt, 2018, Asian journal of andrology.

Why is understanding the relationship of testosterone to cardiovascular risk so important?

B. Yeap, B. Anawalt, 2018, Asian journal of andrology.

Advances in male hormonal contraception

J. Amory, B. Anawalt, 2001, Annals of medicine.

Testosterone administration to normal men decreases truncal and total body fat

K. Herbst, A. Matsumoto, W. Bremner, 1996 .

Associations of Serum Testosterone and Sex Hormone–Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men

G. Hankey, C. Ohlsson, A. Dobs, 2021, Annals of Internal Medicine.

Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System.

T. Dellit, S. Somani, A. Schleyer, 2018, American health & drug benefits.

Male hormonal contraception

Paul B. Cornia, B. Anawalt, Nicole N Grant, 2004, Expert opinion on emerging drugs.

Male hormonal contraceptives

J. Amory, B. Anawalt, 2001, Minerva ginecologica.

Male hormonal contraception: an update on research progress.

B. Anawalt, Nicole N Grant, 2002, Treatments in endocrinology.

High concentrations of LH cause virilization in a postmenopausal woman

B. Anawalt, Iram Ahmad, 2017, Clinical case reports.

Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel

R. Swerdloff, W. Bremner, C. Wang, 2018, Andrology.

Aging and androgens: Physiology and clinical implications.

A. Matsumoto, B. Anawalt, 2022, Reviews in endocrine & metabolic disorders.

Male hypogonadism : an update on diagnosis and treatment.

B. Anawalt, E. Darby, 2005, Treatments in endocrinology.

The silent spermatozoon: are man-made endocrine disruptors killing male fertility?

B. Anawalt, 2013, Asian journal of andrology.

Design of an International Male Contraceptive Efficacy Trial Using a Self-Administered Daily Transdermal Gel Containing Testosterone and Segesterone Acetate (Nestorone®).

R. Swerdloff, W. Bremner, J. Amory, 2023, Contraception.

The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men

R. Swerdloff, A. Meikle, J. Amory, 2008 .

Clinical decisions. Testosterone-replacement therapy.

R. Swerdloff, B. Anawalt, 2014, The New England journal of medicine.

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism.

J. Hotaling, A. Matsumoto, T. Walsh, 2012, The Journal of urology.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.

R. Swerdloff, J. Amory, B. Anawalt, 2007, The Journal of clinical endocrinology and metabolism.

Klinefelter's syndrome

J. Amory, B. Anawalt, C. Paulsen, 1984, The Lancet.